1. Home
  2. SACH vs BDSX Comparison

SACH vs BDSX Comparison

Compare SACH & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

HOLD

Current Price

$1.03

Market Cap

48.6M

Sector

Real Estate

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

BUY

Current Price

$15.75

Market Cap

122.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
SACH
BDSX
Founded
2010
2005
Country
United States
United States
Employees
29
273
Industry
Real Estate Investment Trusts
Precision Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.6M
122.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
SACH
BDSX
Price
$1.03
$15.75
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$2.00
$32.50
AVG Volume (30 Days)
119.2K
122.8K
Earning Date
01-01-0001
05-21-2026
Dividend Yield
19.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,499,000.00
Revenue This Year
N/A
$22.01
Revenue Next Year
$1.58
$26.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$0.80
$0.25
52 Week High
$1.35
$17.40

Technical Indicators

Market Signals
Indicator
SACH
BDSX
Relative Strength Index (RSI) 52.22 75.40
Support Level $1.00 $6.33
Resistance Level $1.13 N/A
Average True Range (ATR) 0.02 1.66
MACD 0.00 0.29
Stochastic Oscillator 57.29 75.30

Price Performance

Historical Comparison
SACH
BDSX

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: